IP Verse

Forty Seven competitive analysis

Explore patent oppositions filed by Forty Seven against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 6, 2026

Patent Number	Title	Applicant	Opposition Date
EP2812443	Cd47 Antibodies And Methods Of Use Thereof	INHIBRX	Feb 28, 2020

Discover the latest PTAB cases involving Forty Seven, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 5, 2026

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Forty Seven
IPR2018-00431	Jan 8, 2018	FORTY SEVEN	STICHTING SANQUIN BLOEDVOORZIENING	Terminated-Settled
IPR2018-00431	Jan 8, 2018	FORTY SEVEN	VAN DEN BERG	Terminated-Settled
IPR2016-01530	Aug 8, 2016	FORTY SEVEN	STICHTING SANQUIN BLOEDVOORZIENING	Institution Denied
IPR2016-01530	Aug 8, 2016	FORTY SEVEN	VAN DEN BERG	Institution Denied
IPR2016-01529	Aug 5, 2016	FORTY SEVEN	STICHTING SANQUIN BLOEDVOORZIENING	Institution Denied
IPR2016-01529	Aug 5, 2016	FORTY SEVEN	VAN DEN BERG	Institution Denied

IP litigation analysis comparing Forty Seven with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 6, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
FORTY SEVEN	1	-	3	-
INHIBRX	-	1	-	-
STICHTING SANQUIN BLOEDVOORZIENING	-	-	-	3
VAN DEN BERG	-	-	-	3